These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15602166)

  • 41. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries.
    Evers SM; Ament AJ; Colombo GL; Konradsen HB; Reinert RR; Sauerland D; Wittrup-Jensen K; Loiseau C; Fedson DS
    Eur J Clin Microbiol Infect Dis; 2007 Aug; 26(8):531-40. PubMed ID: 17570001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysis.
    Schattenberg JM; Lazarus JV; Newsome PN; Serfaty L; Aghemo A; Augustin S; Tsochatzis E; de Ledinghen V; Bugianesi E; Romero-Gomez M; Bantel H; Ryder SD; Boursier J; Leroy V; Crespo J; Castera L; Floros L; Atella V; Mestre-Ferrandiz J; Elliott R; Kautz A; Morgan A; Hartmanis S; Vasudevan S; Pezzullo L; Trylesinski A; Cure S; Higgins V; Ratziu V
    Liver Int; 2021 Jun; 41(6):1227-1242. PubMed ID: 33590598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Language support for linguistic minority chronic hepatitis B/C patients: an exploratory study of availability and clinicians' perceptions of language barriers in six European countries.
    Falla AM; Veldhuijzen IK; Ahmad AA; Levi M; Richardus JH
    BMC Health Serv Res; 2017 Feb; 17(1):150. PubMed ID: 28219385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost of disorders of the brain in Spain.
    Parés-Badell O; Barbaglia G; Jerinic P; Gustavsson A; Salvador-Carulla L; Alonso J
    PLoS One; 2014; 9(8):e105471. PubMed ID: 25133395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic hepatitis B monitoring and treatment patterns in five European countries with different access and reimbursement policies.
    Arama V; Leblebicioglu H; Simon K; Zarski JP; Niederau C; Habersetzer F; Vermehren J; Bludzin W; Jinga M; Ulusoy S; Klauck I; Morais E; Bjork S; Lescrauwaet B; Kamar D; Zeuzem S;
    Antivir Ther; 2014; 19(3):245-57. PubMed ID: 24343051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey.
    Bechini A; Falla A; Ahmad A; Veldhuijzen I; Boccalini S; Porchia B; Levi M
    BMC Infect Dis; 2015 Aug; 15():353. PubMed ID: 26286525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.
    Levy AR; Kowdley KV; Iloeje U; Tafesse E; Mukherjee J; Gish R; Bzowej N; Briggs AH
    Value Health; 2008; 11(3):527-38. PubMed ID: 18179664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis.
    Ju YC; Jun DW; Choi J; Saeed WK; Lee HY; Oh HW
    World J Gastroenterol; 2018 Oct; 24(40):4606-4614. PubMed ID: 30386110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs.
    Augustin AJ; Sahel JA; Cerulli L; Texier-Richard B; Buchholz PM; Kobelt G
    Eur J Ophthalmol; 2012; 22(5):776-84. PubMed ID: 22729442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of invasive cervical cancer and direct costs associated with its management in Italy.
    Ricciardi A; Largeron N; Giorgi Rossi P; Raffaele M; Cohet C; Federici A; Palazzo F
    Tumori; 2009; 95(2):146-52. PubMed ID: 19579858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis B status in migrants and refugees: increasing health burden in Western Australia.
    Subramaniam K; Flexman J; Tarquinio L; Thambiran A; Hopkins S; Cheng W
    Intern Med J; 2012 Aug; 42(8):880-6. PubMed ID: 22212294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain.
    Turnes J; Domínguez-Hernández R; Casado MÁ
    Rev Esp Enferm Dig; 2017 Dec; 109(12):809-817. PubMed ID: 29152988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW; Woo G; Jenny Heathcote E; Krahn M
    Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
    Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
    J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cost of multiple sclerosis in France].
    Fromont A; Lehanneur MN; Rollot F; Weill A; Clerc L; Bonithon Kopp C; Binquet C; Moreau T
    Rev Neurol (Paris); 2014; 170(6-7):432-9. PubMed ID: 24856285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
    Bermingham SL; Hughes R; Fenu E; Sawyer LM; Boxall E; T Kennedy P; Dusheiko G; Hill-Cawthorne G; Thomas H
    Value Health; 2015 Sep; 18(6):800-9. PubMed ID: 26409607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overview of epidemiology and disease burden of hepatitis B in the European region.
    Roure C
    Vaccine; 1995; 13 Suppl 1():S18-21. PubMed ID: 7571821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.
    Gonzalez-McQuire S; Yong K; Leleu H; Mennini FS; Flinois A; Gazzola C; Schoen P; Campioni M; DeCosta L; Fink L
    J Med Econ; 2018 May; 21(5):450-467. PubMed ID: 29278014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.